Summit Therapeutics (SMMT) Exchange Rate Effect (2019 - 2026)
Summit Therapeutics (SMMT) posted Exchange Rate Effect of -$19000.0 for Q1 2026, little changed on a QoQ basis from -$19000.0 in Q4 2025, and down 150.0% year-over-year from $38000.0 in Q1 2025.
Summit Therapeutics (SMMT) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Summit Therapeutics' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$19000.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 150.0% year-over-year to -$19000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45000.0 (down 19.64% YoY) and the FY2025 annual result came in at $102000.0, up 666.67% from the prior year.
- Exchange Rate Effect was -$19000.0 for Q1 2026 at Summit Therapeutics, roughly flat from -$19000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.4 million in Q4 2022 and bottomed at -$1.8 million in Q3 2022.
- A 5-year average of -$18705.9 and a median of $12000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 428.16% in 2022, while the deepest fall reached 621.74% in 2022.
- Summit Therapeutics' Exchange Rate Effect stood at $1.4 million in 2022, then slumped by 80.22% to $272000.0 in 2023, then sank by 139.71% to -$108000.0 in 2024, then jumped by 82.41% to -$19000.0 in 2025, then changed by 0.0% to -$19000.0 in 2026.
- Business Quant data shows SMMT's Exchange Rate Effect at -$19000.0 in Q1 2026, -$19000.0 in Q4 2025, and $22000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Summit Therapeutics | 10.60 Bn | 10.00 Bn | - | -19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19,000.00 |
| Mar 31, 2026 | -19,000.00 |
| Dec 31, 2025 | -19,000.00 |
| Dec 31, 2025 | -19,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Dec 31, 2024 | -108,000.00 |
| Dec 31, 2024 | -108,000.00 |
| Sep 30, 2024 | 114,000.00 |
| Sep 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | -36,000.00 |
| Mar 31, 2024 | -36,000.00 |
| Dec 31, 2023 | 272,000.00 |
| Dec 31, 2023 | 272,000.00 |